search
Back to results

CATCH - Catheter Infections in Children

Primary Purpose

Catheter-related Infections

Status
Completed
Phase
Phase 3
Locations
United Kingdom
Study Type
Interventional
Intervention
Standard polyurethane Central Venous Catheter
Antibiotic impregnated polyurethane CVC (minocycline and rifampicin)
Heparin bonded polyurethane CVC
Sponsored by
Institute of Child Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Catheter-related Infections focused on measuring Central Venous Catheters, blood stream infection, children, intensive care, Heparin bonded, antibiotic coated, Children in Paediatric Intensive Care Unit

Eligibility Criteria

undefined - 16 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Weighing ≥3kg and less than 16 years of age;
  • Admitted to or being prepared for admission to an intensive care unit participating in the trial;
  • Require insertion of a polyurethane CVC as part of good clinical management;
  • Require one of the CVC sizes available to the trial (see Appendix A for the list of CVCs);
  • Expected to require a CVC for at least 3 days;
  • Appropriate consent obtained (prospective consent for elective surgical patients, deferred consent for emergency admission patients).

Sites / Locations

  • Institute of Child Health

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Standard polyurethane Central Venous Catheter

Antibiotic impregnated polyurethane CVC

Heparin bonded polyurethane CVC

Arm Description

Standard polyurethane Central Venous Catheter All CVCs used in the trial are CE marked medical devices used for their intended purpose.

Antibiotic impregnated polyurethane CVC (minocycline and rifampicin) All CVCs used in the trial are CE marked medical devices used for their intended purpose.

Heparin bonded polyurethane CVC All CVCs used in the trial are CE marked medical devices used for their intended purpose.

Outcomes

Primary Outcome Measures

The primary outcome will be time to first blood stream infection defined by a positive blood culture from a sample that was clinically indicated and taken more than 48 hours after CVC insertion and up to 48 hours after CVC removal.

Secondary Outcome Measures

Full Information

First Posted
December 9, 2009
Last Updated
February 15, 2022
Sponsor
Institute of Child Health
search

1. Study Identification

Unique Protocol Identification Number
NCT01029717
Brief Title
CATCH - Catheter Infections in Children
Official Title
A Randomised Controlled Trial Comparing the Effectiveness of Heparin Bonded or Antibiotic Impregnated Central Venous Catheters (CVCs) With Standard CVCs for the Prevention of Hospital Acquired Blood Stream Infection in Children
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
December 2010 (Actual)
Primary Completion Date
November 2012 (Actual)
Study Completion Date
November 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute of Child Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Most children admitted to paediatric intensive care units (PICU) need to have medicines given to them into their veins using a narrow tube, so they do not need repeated injections. This tube is called a central venous catheter. Occasionally these catheters can cause infections in the blood and sometimes the tubes can get blocked by small blood clots. Some intensive care units already use antibiotic or heparin coated catheters, but there is no proof that these are better than the standard ones at preventing infections. Most of the PICU's in this country use standard lines. The only way to find out for certain is to compare children who are given antibiotic or heparin coated catheters with those who are given standard ones in a clinical trial. Because we do not know which type of catheter is best, the type of catheter each child receives in the study will be decided randomly by chance. Each child in the trial will have the same chance of getting any of these three catheters: Standard central venous catheter (not coated). Heparin coated central venous catheter. Heparin is a medicine that can stop blood from clotting and might stop the tubes being blocked and infections in the blood. Antibiotic coated central venous catheter. Antibiotics can be used to kill bacteria which cause the infections. The aim of this study is to see how the three types of catheters compare in reducing the amount of blood infections in children. We will also look at the costs involved. We hope to recruit 1200 children in the UK over 2 years. We hope that the information we get from this study will guide policy about purchasing impregnated Central Venous Catheters across the NHS and thereby improve treatment for children in the future.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Catheter-related Infections
Keywords
Central Venous Catheters, blood stream infection, children, intensive care, Heparin bonded, antibiotic coated, Children in Paediatric Intensive Care Unit

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1859 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard polyurethane Central Venous Catheter
Arm Type
Experimental
Arm Description
Standard polyurethane Central Venous Catheter All CVCs used in the trial are CE marked medical devices used for their intended purpose.
Arm Title
Antibiotic impregnated polyurethane CVC
Arm Type
Active Comparator
Arm Description
Antibiotic impregnated polyurethane CVC (minocycline and rifampicin) All CVCs used in the trial are CE marked medical devices used for their intended purpose.
Arm Title
Heparin bonded polyurethane CVC
Arm Type
Active Comparator
Arm Description
Heparin bonded polyurethane CVC All CVCs used in the trial are CE marked medical devices used for their intended purpose.
Intervention Type
Device
Intervention Name(s)
Standard polyurethane Central Venous Catheter
Intervention Description
Standard polyurethane Central Venous Catheter, All CVCs used in the trial are CE marked medical devices used for their intended purpose.
Intervention Type
Device
Intervention Name(s)
Antibiotic impregnated polyurethane CVC (minocycline and rifampicin)
Intervention Description
Antibiotic impregnated polyurethane CVC (minocycline and rifampicin. All CVCs used in the trial are CE marked medical devices used for their intended purpose.
Intervention Type
Device
Intervention Name(s)
Heparin bonded polyurethane CVC
Intervention Description
Heparin bonded polyurethane CVC. All CVCs used in the trial are CE marked medical devices used for their intended purpose.
Primary Outcome Measure Information:
Title
The primary outcome will be time to first blood stream infection defined by a positive blood culture from a sample that was clinically indicated and taken more than 48 hours after CVC insertion and up to 48 hours after CVC removal.
Time Frame
48 HOURS

10. Eligibility

Sex
All
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Weighing ≥3kg and less than 16 years of age; Admitted to or being prepared for admission to an intensive care unit participating in the trial; Require insertion of a polyurethane CVC as part of good clinical management; Require one of the CVC sizes available to the trial (see Appendix A for the list of CVCs); Expected to require a CVC for at least 3 days; Appropriate consent obtained (prospective consent for elective surgical patients, deferred consent for emergency admission patients).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruth Gilbert, Professor
Organizational Affiliation
Institute of Child Health
Official's Role
Study Director
Facility Information:
Facility Name
Institute of Child Health
City
London
ZIP/Postal Code
WC1N 1EH
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
10990114
Citation
Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med. 2000 Jul;26(7):967-72. doi: 10.1007/s001340051289.
Results Reference
background
PubMed Identifier
26935961
Citation
Harron K, Mok Q, Dwan K, Ridyard CH, Moitt T, Millar M, Ramnarayan P, Tibby SM, Muller-Pebody B, Hughes DA, Gamble C, Gilbert RE. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children. Health Technol Assess. 2016 Mar;20(18):vii-xxviii, 1-219. doi: 10.3310/hta20180.
Results Reference
result
PubMed Identifier
26438711
Citation
Harron K, Woolfall K, Dwan K, Gamble C, Mok Q, Ramnarayan P, Gilbert R. Deferred Consent for Randomized Controlled Trials in Emergency Care Settings. Pediatrics. 2015 Nov;136(5):e1316-22. doi: 10.1542/peds.2015-0512. Epub 2015 Oct 5.
Results Reference
derived
Links:
URL
https://www.journalslibrary.nihr.ac.uk/hta/hta20180/
Description
National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Report of the study

Learn more about this trial

CATCH - Catheter Infections in Children

We'll reach out to this number within 24 hrs